(Q53911489)

22 May 2018

title

Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. (English)

1 reference

22 May 2018

dementia with Lewy bodies

main subject

dementia

0 references

1 reference

3

1 reference

22 May 2018

Ian G. McKeith

0 references

author name string

McKeith IG

1

1 reference

22 May 2018

Grace JB

2

1 reference

22 May 2018

Byrne EJ

4

1 reference

22 May 2018

Wilkinson D

5

1 reference

22 May 2018

Stevens T

6

1 reference

22 May 2018

Perry EK

7

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 May 2000

1 reference

22 May 2018

International Journal of Geriatric Psychiatry

published in

1 reference

22 May 2018

volume

15

1 reference

22 May 2018

issue

5

1 reference

22 May 2018

page(s)

387-392

1 reference

22 May 2018

Physostigmine ameliorates the delusions of Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

Dementia with Lewy bodies: response of delirium-like features to donepezil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

Lewy bodies and response to tacrine in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

Neuroleptic sensitivity to risperidone in Lewy body dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

Tacrine for senile dementia of Alzheimer's or Lewy body type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28200005%2915%3A5%3C387%3A%3AAID-GPS131%3E3.0.CO%3B2-9

10.1002/(SICI)1099-1166(200005)15:5<387::AID-GPS131>3.0.CO;2-9

21 January 2018

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

10822236

1 reference

22 May 2018